JP2014144959A5 - - Google Patents

Download PDF

Info

Publication number
JP2014144959A5
JP2014144959A5 JP2014040627A JP2014040627A JP2014144959A5 JP 2014144959 A5 JP2014144959 A5 JP 2014144959A5 JP 2014040627 A JP2014040627 A JP 2014040627A JP 2014040627 A JP2014040627 A JP 2014040627A JP 2014144959 A5 JP2014144959 A5 JP 2014144959A5
Authority
JP
Japan
Prior art keywords
test sample
tumor
adam8
control
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014040627A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014144959A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014144959A publication Critical patent/JP2014144959A/ja
Publication of JP2014144959A5 publication Critical patent/JP2014144959A5/ja
Pending legal-status Critical Current

Links

JP2014040627A 1999-07-28 2014-03-03 腫瘍治療のための組成物と方法 Pending JP2014144959A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14621799P 1999-07-28 1999-07-28
US60/146,217 1999-07-28

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2011231764A Division JP5897300B2 (ja) 1999-07-28 2011-10-21 腫瘍治療のための組成物と方法

Publications (2)

Publication Number Publication Date
JP2014144959A JP2014144959A (ja) 2014-08-14
JP2014144959A5 true JP2014144959A5 (2) 2015-01-29

Family

ID=22516336

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2001513995A Withdrawn JP2003508028A (ja) 1999-07-28 2000-07-27 腫瘍治療のための組成物と方法
JP2011231764A Expired - Lifetime JP5897300B2 (ja) 1999-07-28 2011-10-21 腫瘍治療のための組成物と方法
JP2014040627A Pending JP2014144959A (ja) 1999-07-28 2014-03-03 腫瘍治療のための組成物と方法

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2001513995A Withdrawn JP2003508028A (ja) 1999-07-28 2000-07-27 腫瘍治療のための組成物と方法
JP2011231764A Expired - Lifetime JP5897300B2 (ja) 1999-07-28 2011-10-21 腫瘍治療のための組成物と方法

Country Status (9)

Country Link
US (2) US7226596B2 (2)
EP (1) EP1204682B1 (2)
JP (3) JP2003508028A (2)
AT (1) ATE488529T1 (2)
AU (1) AU776600B2 (2)
CA (1) CA2378182C (2)
DE (1) DE60045247D1 (2)
ES (1) ES2355055T3 (2)
WO (1) WO2001009189A2 (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE488529T1 (de) * 1999-07-28 2010-12-15 Genentech Inc Zusammensetzungen und verfahren zur behandlung von tumoren
CA2462133A1 (en) * 2002-02-20 2003-08-28 Kunitake Abe Novel polypeptide
CN1854313B (zh) * 2002-09-30 2010-10-20 肿瘤疗法科学股份有限公司 非小细胞肺癌的诊断方法
WO2005011619A2 (en) * 2003-01-31 2005-02-10 Five Prime Therapeutics, Inc. Lung-expressed polypeptides
EP1730533A1 (en) * 2004-03-24 2006-12-13 Oncotherapy Science, Inc. Adam8 as tumor marker and therapeutic target for non-small cell lung cancer
ES2318575T3 (es) * 2004-11-10 2009-05-01 Novartis Vaccines And Diagnostics, Inc. Interferon beta desamidado.
FR2879462B1 (fr) * 2004-12-21 2008-12-26 Sod Conseils Rech Applic Utilisation de toxine botulique pour une insensibilisation locale prolongee
EP2290087A3 (en) * 2004-12-22 2011-06-15 Genentech, Inc. Methods for producing soluble multi-membrane-spanning proteins
US20060242012A1 (en) * 2005-04-22 2006-10-26 Sumit Agarwal Determining or scoring properties to solicit to join ad network using advertiser or aggregated advertiser interest
EP2102244A2 (en) 2006-12-19 2009-09-23 Ablynx N.V. Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders
US20090304719A1 (en) 2007-08-22 2009-12-10 Patrick Daugherty Activatable binding polypeptides and methods of identification and use thereof
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
EP2225563B1 (en) * 2007-11-27 2015-01-21 Janssen Diagnostics, LLC Automated enumeration and characterization of circulating melanoma cells in blood
RU2636046C2 (ru) 2009-01-12 2017-11-17 Сайтомкс Терапьютикс, Инк Композиции модифицированных антител, способы их получения и применения
AU2010215761B2 (en) 2009-02-23 2017-04-06 Cytomx Therapeutics, Inc Proproteins and methods of use thereof
EP2996721B1 (en) * 2013-05-13 2021-10-06 Tufts University Compositions for treatment of adam8-expressing cancer
TW201613621A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for promoting growth of dermal papilla cells, pharmaceutical composition, and preparation method thereof
TW201613622A (en) * 2014-10-14 2016-04-16 Bionet Corp Composition for skincare and pharmaceutical composition and preparation method thereof
JP2018130113A (ja) * 2017-02-15 2018-08-23 国立大学法人 東京大学 慢性骨髄性白血病（ｃｍｌ）の検査方法及び検査用キット、チロシンキナーゼ阻害剤（ｔｋｉ）耐性ｃｍｌの単離方法、並びにｃｍｌにおけるｔｋｉ耐性の低減剤及びそのスクリーニング方法
EP3976655A4 (en) 2019-05-31 2023-07-05 Trustees of Tufts College Anti-adam8 antibodies and uses of the same

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04187084A (ja) * 1990-11-22 1992-07-03 Otsuka Pharmaceut Co Ltd 単球表面に発現する抗原及び該抗原に対するモノクローナル抗体
PT822186E (pt) * 1994-01-20 2000-08-31 British Biotech Pharm L-tert-leucina-2-piridilamida
GB9608130D0 (en) 1996-04-19 1996-06-26 Univ Sheffield Adam proteins and uses thereof
WO1998031394A2 (en) 1997-01-22 1998-07-23 Board Of Regents, The University Of Texas System Tissue factor methods and compositions for coagulation and tumor treatment
GB9705521D0 (en) * 1997-03-18 1997-05-07 Univ Sheffield The use of mononuclear phagocytes in the vivo imaging of hypoxic/ischaemic tissue
US5922566A (en) * 1997-05-13 1999-07-13 Incyte Pharmaceuticals, Inc. Tumor-associated antigen
WO1999064626A2 (en) * 1998-06-06 1999-12-16 Genostic Pharma Limited Probes used for genetic profiling
CA2702148C (en) * 1999-01-06 2014-03-04 Genenews Inc. Method of profiling gene expression in a human subject having an infectious disease
US20010034023A1 (en) * 1999-04-26 2001-10-25 Stanton Vincent P. Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
ATE488529T1 (de) * 1999-07-28 2010-12-15 Genentech Inc Zusammensetzungen und verfahren zur behandlung von tumoren
NZ521437A (en) * 2000-02-25 2004-04-30 Immunex Corp Integrin antagonists suitable as inhibitors of angiogenesis
IL151872A0 (en) * 2000-03-24 2003-04-10 Micromet Ag mRNA AMPLIFICATION
US6458552B1 (en) * 2000-06-06 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Metalloprotease peptide substrates and methods
US6818401B2 (en) * 2000-10-02 2004-11-16 Board Of Regents University Of Texas System Method of detection and interpretation of mutations through expression or function tests of haploid genes
US20030154032A1 (en) * 2000-12-15 2003-08-14 Pittman Debra D. Methods and compositions for diagnosing and treating rheumatoid arthritis
WO2002085285A2 (en) * 2001-04-18 2002-10-31 Wyeth Methods and reagents for regulating bone and cartilage formation
US20030138792A1 (en) * 2001-05-31 2003-07-24 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
US20030148316A1 (en) * 2001-08-01 2003-08-07 Lipford Grayson B. Methods and compositions relating to plasmacytoid dendritic cells
US20030148334A1 (en) * 2001-10-12 2003-08-07 Zairen Sun Differentially-expressed genes and polypeptides in angiogenesis
CA2477400A1 (en) * 2002-03-01 2003-09-12 Marc Rothenberg Treatment for asthma or allergies
US20040018522A1 (en) * 2002-05-09 2004-01-29 Brigham And Women's Hospital, Inc. Identification of dysregulated genes in patients with multiple sclerosis
US20050003390A1 (en) * 2002-05-17 2005-01-06 Axenovich Sergey A. Targets for controlling cellular growth and for diagnostic methods
JP2004041121A (ja) * 2002-07-12 2004-02-12 Hitachi Ltd アレルギー解析方法及びシステム
WO2004058052A2 (en) * 2002-12-20 2004-07-15 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
US8088737B2 (en) * 2003-04-04 2012-01-03 Incyte Corporation Compositions, methods and kits relating to Her-2 cleavage
US20050009067A1 (en) * 2003-05-19 2005-01-13 Craig Logsdon Expression profile of pancreatic cancer
WO2005026325A2 (en) * 2003-09-10 2005-03-24 Surromed, Inc, Bivalent targeting of cell surfaces

Similar Documents

Publication Publication Date Title
JP2014144959A5 (2)
Harouaka et al. Circulating tumor cells: advances in isolation and analysis, and challenges for clinical applications
JP2016500110A5 (2)
Tu et al. Luminescent biodetection based on lanthanide-doped inorganic nanoprobes
MX2020001156A (es) Metodo para el pronostico y tratamiento de metastasis de cancer.
MX361058B (es) Método para detectar células tumorales circulantes 5t4-positivas y métodos de diagnóstico de cáncer 5t4-positivo en un sujeto mamífero.
EA201792497A1 (ru) Антитела к gitr для диагностики злокачественной опухоли
GB2488700B (en) Methods for monitoring disease conditions by analysis of the full repertoire of CDR3 sequences of an individual
RU2015125575A (ru) Композиции и способы для лечения злокачественной опухоли
JP2016507233A5 (2)
WO2015094996A3 (en) Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
WO2018007872A9 (en) Biomarkers for inflammatory bowel disease
WO2011112903A3 (en) Quantitative rt-pcr detection for genes involved in epithelial mesenchymal transition in peripheral blood of breast cancer patients
EP3159695A3 (en) Methods for diagnosing pancreatic cancer
WO2016198833A3 (en) Methods for analysing a urine sample
JP2017503481A5 (2)
WO2014028862A9 (en) Use of dna in circulating exosomes as a diagnostic marker for metastasic disease
EP2619587A4 (en) BIOMARKER FOR PREDICTING THE REPRODUCTION OF A COLORECTAL CARCINOMA
WO2015077382A3 (en) Combined cytology and molecular testing for early detection of esophageal adenocarcinoma
WO2015082416A8 (en) Novel rna-biomarkers for diagnosis of prostate cancer
Gao et al. Effects of miR-16 plus CA19-9 detections on pancreatic cancer diagnostic performance
WO2015023503A3 (en) Compositions and methods for multimodal analysis of cmet nucleic acids
JP2014501929A5 (2)
WO2014177867A3 (en) Differentially expressed biomarkers for alzheimer's disease
Lopez-Munoz et al. Markers of circulating breast cancer cells